• Biodexa Pharmaceuticals announced an ADS ratio change to 1 ADS representing 400 ordinary shares, from 50 previously.
• Change is expected to take effect on or about Oct. 26, 2026.
• Move has the same effect as a one-for-eight reverse ADS split for ADS holders.
• Ordinary shares are not affected.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Biodexa Pharmaceuticals plc published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001214659-26-012706), on October 08, 2026, and is solely responsible for the information contained therein.